160 related articles for article (PubMed ID: 30720372)
1. From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines.
Mura S; Fattal E; Nicolas J
J Drug Target; 2019; 27(5-6):470-501. PubMed ID: 30720372
[TBL] [Abstract][Full Text] [Related]
2. A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles.
Vauthier C
J Drug Target; 2019; 27(5-6):502-524. PubMed ID: 30889991
[TBL] [Abstract][Full Text] [Related]
3. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
Nicolas J; Couvreur P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):111-127. PubMed ID: 20049783
[TBL] [Abstract][Full Text] [Related]
5. (Poly-cyanoacrylate) nanomedicines for cancer and beyond: Lessons learned.
Couvreur P
J Control Release; 2021 Jun; 334():318-326. PubMed ID: 33915223
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.
Sulheim E; Baghirov H; von Haartman E; Bøe A; Åslund AK; Mørch Y; Davies Cde L
J Nanobiotechnology; 2016 Jan; 14():1. PubMed ID: 26743777
[TBL] [Abstract][Full Text] [Related]
7. Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization.
Liang M; Davies NM; Toth I
Int J Pharm; 2008 Oct; 362(1-2):141-6. PubMed ID: 18598746
[TBL] [Abstract][Full Text] [Related]
8. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P
ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248
[TBL] [Abstract][Full Text] [Related]
9. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
Lai P; Daear W; Löbenberg R; Prenner EJ
Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
[TBL] [Abstract][Full Text] [Related]
10. Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles.
Dormont F; Rouquette M; Mahatsekake C; Gobeaux F; Peramo A; Brusini R; Calet S; Testard F; Lepetre-Mouelhi S; Desmaële D; Varna M; Couvreur P
J Control Release; 2019 Aug; 307():302-314. PubMed ID: 31260754
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel cyanoacrylate monomers for use in nanoparticle drug delivery systems prepared by miniemulsion polymerisation - A multistep screening approach.
Hyldbakk A; Mørch Y; Snipstad S; Åslund AKO; Klinkenberg G; Nakstad VT; Wågbø AM; Schmid R; Molesworth PP
Int J Pharm X; 2022 Dec; 4():100124. PubMed ID: 35898812
[TBL] [Abstract][Full Text] [Related]
12. Towards a clinical application of freeze-dried squalene-based nanomedicines.
Rouquette M; Ser-Le Roux K; Polrot M; Bourgaux C; Michel JP; Testard F; Gobeaux F; Lepetre-Mouelhi S
J Drug Target; 2019; 27(5-6):699-708. PubMed ID: 30786788
[TBL] [Abstract][Full Text] [Related]
13. Poly(alkylcyanoacrylate) nanoparticles for enhanced delivery of therapeutics - is there real potential?
Graf A; McDowell A; Rades T
Expert Opin Drug Deliv; 2009 Apr; 6(4):371-87. PubMed ID: 19382881
[TBL] [Abstract][Full Text] [Related]
14. Cabazitaxel-loaded poly(alkyl cyanoacrylate) nanoparticles: toxicity and changes in the proteome of breast, colon and prostate cancer cells.
Øverbye A; Torgersen ML; Sønstevold T; Iversen TG; Mørch Ý; Skotland T; Sandvig K
Nanotoxicology; 2021 Sep; 15(7):865-884. PubMed ID: 34047629
[TBL] [Abstract][Full Text] [Related]
15. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
16. Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging.
Brambilla D; Nicolas J; Le Droumaguet B; Andrieux K; Marsaud V; Couraud PO; Couvreur P
Chem Commun (Camb); 2010 Apr; 46(15):2602-4. PubMed ID: 20449321
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
18. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of polycyanoacrylates.
Barkan Y; Levinman M; Veprinsky-Zuzuliya I; Tsach T; Merqioul E; Blum G; Domb AJ; Basu A
Acta Biomater; 2017 Jan; 48():390-400. PubMed ID: 27826005
[TBL] [Abstract][Full Text] [Related]
20. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.
Huang CY; Lee YD
Int J Pharm; 2006 Nov; 325(1-2):132-9. PubMed ID: 16857330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
